MondayMorning back issues from January 2008:
Philips agrees to buy respironics.(TOP STORIES)(Koninklijke Philips Electronics N.V. buys Respironics Inc.)(Brief article)
Jan 07, 2008 ... Philips Agrees to buy respironics. Royal Philips Electronics NV, the world's biggest manufacturer of patient-monitoring systems, agreed to buy medical-device maker Respironics Inc. (Murraysville PA) for 3.6 billion euros ($5.2 billion) in its largest-ever acquisition. Philips will pay $66 ...
Federal Judge wants closer look at UnitedHealth settlement.(TOP STORIES)(cases of UnitedHealth Group Inc. with its former chairman William McGuire)(Brief article)
Jan 07, 2008 ... Federal Judge wants closer look at UnitedHealth settlement. A settlement between UnitedHealth Group Inc. (Minnetonka MN) and its former CEO could be in danger after a federal judge wrote that he wants to know whether he can examine its merits. U.S. District Court Judge James Rosenbaum ...
Merck to pay $700 million for development of schizophrenia drug.(TOP STORIES)(Brief article)
Jan 07, 2008 ... Merck to Pay $700 Million for Development of Schizophrenia Drug. Addex Pharmaceuticals of Switzerland said it has reached a deal with Merck & Co. (Whitehouse Station NJ) to develop a drug for schizophrenia, under which the American drug giant will pay the Swiss firm up to $702 million ...
American Dental Partners Inc. (Nasdaq) led advancing issues, soaring $3.84, or 70% on the week, to $9.36. The company, which provides business services to dental practices, said it settled a breach of contract lawsuit with PDG PA.(Medical Stock Spotlight)(Brief article)
Jan 07, 2008 ... Medical Stock Spotlight: American Dental Partners Inc. (Nasdaq) led advancing issues, soaring $3.84, or 70% on the week, to $9.36. The company, which provides business services to dental practices, said it settled a breach of contract lawsuit with PDG PA. The PDG dental group operates the ...
Ohio supreme court rules on pain and suffering damages.(TOP STORIES)(Brief article)
Jan 07, 2008 ... Ohio Supreme Court Rules on Pain and Suffering Damages. The Ohio Supreme Court upheld a state law that limits how much a person injured by a defective product can collect in pain-and-suffering damages, reversing its stance on a closely watched issue. Attorneys representing injured people ...
Johnson & Johnson's (New Brunswick NJ) Duragesic pain patch and its generic equivalents received a second safety warning from U.S. regulators, who said improper use continues to cause deaths and life-threatening breathing difficulty.(Tracking Washington)(Brief article)
Jan 07, 2008 ... Tracking Washington: Johnson & Johnson's (New Brunswick NJ) Duragesic pain patch and its generic equivalents received a second safety warning from U.S. regulators, who said improper use continues to cause deaths and life-threatening breathing difficulty. The Food and Drug Administration ...
Abbott's Humira gets EU approval as psoriasis therapy.(CORPORATE)(Abbott Laboratories)(European Union)(Brief article)
Jan 07, 2008 ... Abbott's Humira gets EU approval as psoriasis therapy. Abbott Laboratories Inc. (Abbott Park IL) won European approval to market the arthritis drug Humira as a treatment for moderate to severe forms of psoriasis. Psoriasis is the fifth approved use of Humira in the 27 countries of the ...
Generic drugmakers allowed to make OTC Zyrtec.(CORPORATE)(over the counter drugs)(Brief article)
Jan 07, 2008 ... Generic Drugmakers Allowed to Make OTC Zyrtec. Mylan Inc. (Canonsburg PA), the world's third-largest maker of generic drugs, Perrigo Co. (Allegan MI) and Caraco Pharmaceutical Laboratories Ltd. (Detroit MI) all won U.S. approval to copy Johnson & Johnson's (New Brunswick NJ) ...
Boston scientific Corp.(CORPORATE)(marketing approval for Livian)(Brief article)
Jan 07, 2008 ... BOSTON SCIENTIFIC CORP. (Natick MA), the second-largest maker of heart devices, received marketing approval in Europe for its implantable Livian, used to monitor heartbeats and deliver electrical jolts to improve pumping ability. The Livian device, ...
Cleveland Biolabs Inc.(CORPORATE)(Brief article)
Jan 07, 2008 ... CLEVELAND BIOLABS INC. (Cleveland OH) saw its shares fall 60% on the week to $3.31 after it lost a $225 million U.S. defense contract to Osiris Therapeutics Inc. (Columbia MD) for a radiation sickness treatment. Osiris, the only company with a stem cell product on the market, rose 10% to ...
Cubist Pharmaceuticals Inc.(CORPORATE)(Cubist Pharmaceuticals Inc. acquired Seattlebased Illumigen Biosciences Inc.)(Brief article)
Jan 07, 2008 ... CUBIST PHARMACEUTICALS INC. (Lexington MA) said it acquired Seattlebased Illumigen Biosciences Inc., which is developing a protein therapeutic to treat Hepatitis C virus infections, for $9 million in cash. Cubist said it expects to file an investigational new drug application in ...
Siemens Ag.(CORPORATE)(Brief article)
Jan 07, 2008 ... SIEMENS AG. was warned by U.S. regulators that it must stop marketing an unapproved device to evaluate the risk of heart disease. The Syngo Arterial Health Package, promoted for use with several of the company's ultrasound systems, lacks required approval, the Food and Drug Administration ...
Barr Laboratories Inc. (Pomona NY) won approval to market a generic version of Roche Laboratories Inc.'s Kytril medication, used to prevent cancer therapy-related nausea and vomiting.(FDA ROUNDUP)(briefs)(Brief article)
Jan 07, 2008 ... FDA ROUNDUP: Barr Laboratories Inc. (Pomona NY) won approval to market a generic version of Roche Laboratories Inc.'s Kytril medication, used to prevent cancer therapy-related nausea and vomiting. Elsewhere, Becton Dickinson & Co. (Franklin Lakes NJ) was cleared to sell its two-hour staph ...
Weekly Stock Performance (as of January 4, 2008).(Statistical table)
Jan 07, 2008 ... <Pre> GROUPCLOSECHG WEEK P/E % CHG RATIO Providers/HMOs CVS/Caremark 37.27 -2.73 -6.83 20.2 DaVita 54.93 -1.08 -1.93 15.9 HealthSouth ...
The U.S. stock market got off to its worst start since 2000 after government reports on jobs and manufacturing added to concern that the economy will sink into recession.(Markets)(Brief article)
Jan 07, 2008 ... Markets: The U.S. stock market got off to its worst start since 2000 after government reports on jobs and manufacturing added to concern that the economy will sink into recession. Intel Corp., the largest chipmaker, was downgraded by JP Morgan Chase, and blue-chip stocks Alcoa Inc., Home ...
Included among recent SEC filings for initial public offerings, Prometheus Laboratories Inc. (San Diego CA) registered up to $100 million worth of common stock via Goldman Sachs.(IPO Sector)(Securities and Exchange Commission)(Brief article)
Jan 07, 2008 ... IPO Sector: Included among recent SEC filings for initial public offerings, Prometheus Laboratories Inc. (San Diego CA) registered up to $100 million worth of common stock via Goldman Sachs. No details were furnished about the number of shares to be offered or a price range for each share ....
Weekly Key Rates in percent.(Statistical table)(Brief article)
Jan 07, 2008 ... <Pre> Weekly Key Rates Prev. Year in percent1/4/08 WeekAgo Prime rate 7.25 7.258.25 Federal funds 4.25 4.255.25 3-Month Libor 4.97 4.735.36 ...
Findings from a meta analysis lend support to the hypothesis that statins have an anti-arrhythmic effect.(RESEARCH & TECHNOLOGY)(Brief article)(Clinical report)
Jan 07, 2008 ... Findings from a meta analysis lend support to the hypothesis that statins have an anti-arrhythmic effect. The study shows that statins are "associated with a significant 19% reduction for sudden cardiac death." Dr. Giacom Levantesi and colleagues at Consorzio Mario Negri Sud, Santa Maria ...
Thousands of deaths may occur in US hospitals yearly because doctors fail to respond within two minutes to help patients in cardiac arrest, a study suggests.(RESEARCH & TECHNOLOGY)(Brief article)
Jan 07, 2008 ... Thousands of deaths may occur in US hospitals yearly because doctors fail to respond within two minutes to help patients in cardiac arrest, a study suggests. In almost one in three cases, doctors didn't administer electric shocks needed to restart the heart within the time guidelines, ...
Lawyers for hundreds of people who sued Merck & Co (Whitehouse Station NJ) over its withdrawn painkiller Vioxx are challenging a key provision of a proposed settlement that requires lawyers to advise all or none of their clients to accept the deal.(Brief article)
Jan 07, 2008 ... Lawyers for hundreds of people who sued Merck & Co (Whitehouse Station NJ) over its withdrawn painkiller Vioxx are challenging a key provision of a proposed settlement that requires lawyers to advise all or none of their clients to accept the deal. Plaintiffs lawyers who negotiated the ...
Endo Pharmaceuticals Holdings Inc (Chadds Ford PA) agreed to pay as much as $50 million for North American rights to develop and sell Alexza Pharmaceuticals Inc's (Palo Alto CA) inhaled painkiller system.(Brief article)
Jan 07, 2008 ... Endo Pharmaceuticals Holdings Inc (Chadds Ford PA) agreed to pay as much as $50 million for North American rights to develop and sell Alexza Pharmaceuticals Inc's (Palo Alto CA) inhaled painkiller system. Endo will pay $10 million up front for the exclusive rights to Alexza's AZ-003, a ...
New Jersey will require all pregnant women to be tested for HIV unless they opt out under legislation signed into law by Richard Codey, the Senate president serving as acting governor while John Corozine was on vacation.(Brief article)
Jan 07, 2008 ... New Jersey will require all pregnant women to be tested for HIV unless they opt out under legislation signed into law by Richard Codey, the Senate president serving as acting governor while John Corozine was on vacation. Healthcare providers will test pregnant women for HIV, the virus that ...
FDA approves 19 new U.S. drugs in 2007; fewest since '83.(TOP STORIES)(Food and Drug Administration )(Brief article)
Jan 14, 2008 ... The U.S. Food and Drug Administration approved only 19 new drugs in 2007, the fewest in 24 years, after drugmakers focused on developing uses for existing products. The number of new medicines, including those made with novel chemical ingredients and using biotechnology, was three less ...
Advanced cell makes stem cells without harming embryo.(TOP STORIES)(Advanced Cell Technology Inc.)(Brief article)
Jan 14, 2008 ... Advanced Cell Technology Inc. (Alameda CA) scientists say they perfected a method to create new lines of stem cells from a human embryo that doesn't harm the embryo and may help overcome ethical concerns about the research. The method involves extracting one or two cells from a human ...
Among rich nations, US has highest rate of preventable deaths.(TOP STORIES)(Brief article)
Jan 14, 2008 ... More than 100,000 Americans die each year from a lack of timely, effective medical care, according to a study that found the U.S. has the highest rate of preventable deaths among 19 industrialized nations. In the five years through 2003, the rate of preventable deaths in the U.S. declined ...
Medtronic to buy 15% of Weigao for $221 million.(TOP STORIES)(Medtronic Inc. acquires Shandong Weigao Group Medical Polymer Co.)(Brief article)
Jan 14, 2008 ... Medtronic Inc. (Minneapolis MN), the largest maker of medical devices for the spine, expanded its presence in China by agreeing to buy a minority stake in the country's biggest device manufacturer. Medtronic plans to purchase 15% of the shares of Shandong Weigao Group Medical Polymer Co ....
Medicare spending jumped 19% in 2006, the fastest rate of growth in 25 years, after a prescription drug benefit was added to the U.S. healthcare program.(Tracking Washington)(Brief article)
Jan 14, 2008 ... Tracking Washington: Medicare spending jumped 19% in 2006, the fastest rate of growth in 25 years, after a prescription drug benefit was added to the U.S. healthcare program. Overall, the nation's healthcare costs rose 6.7% to $2.1 trillion, or $7,026 per person, and made up 16% of the ...
Amgen stock jumps as 2007 profit beats forecast.(CORPORATE)(revenue report)(Financial report)(Brief article)
Jan 14, 2008 ... Amgen Inc. (Thousand Oaks CA), the world's largest biotech company, rose the most in four months last week after CEO Kevin Sharer said the company beat its 2007 profit forecast because of spending cuts. Earnings exceed the Oct. 24 range of $4.13 to $4.23 a share when certain costs are ...
Genzyme says 4Q revenue rose 21%.(CORPORATE)(revenue report)(Financial report)(Brief article)
Jan 14, 2008 ... Genzyme Corp. (Cambridge MA), the maker of treatments for rare genetic disorders, said fourth-quarter revenue rose 21% to $1.04 billion, beating Wall Street's forecast. Revenue for the year leaped 20% to $3.8 billion. The company was expected to generate $991 million in sales for the ...
Biogen Idec Inc.(CORPORATE)(revenue report)(Financial report)(Brief article)
Jan 14, 2008 ... BIOGEN IDEC INC. (Cambridge MA), the U.S. drugmaker that failed last month to find a buyer, saw its shares jump after forecasting a revenue gain of as much as 20% this year. Sales of Tysabri, a once-withdrawn treatment for multiple sclerosis, will drive revenue and help fuel adjusted ...
Celgene Corp.(CORPORATE)(financial report)(Financial report)(Brief article)
Jan 14, 2008 ... CELGENE CORP. (Summit NJ), the maker of thalidomide-based cancer drugs, gained on the Nasdaq Stock Market after it said fourth-quarter sales of its top-selling product exceeded Wall Street's estimates. Celgene said it expects to generate $240 million to $245 million in fourth-quarter sales ...
Cubist Pharmaceuticals Inc.(CORPORATE)(revenue report)(Financial report)(Brief article)
Jan 14, 2008 ... CUBIST PHARMACEUTICALS INC. (Lexington MA) said its product revenue rose by nearly half in the fourth quarter on strong demand for its Cubicin antibiotic. The pharmaceutical company posted revenue of $83.9 million last quarter, up 48.8% from $56.4 million in the ...
Isis Pharmaceuticals Inc.(CORPORATE)(Brief article)
Jan 14, 2008 ... ISIS PHARMACEUTICALS INC. (Carlsbad CA) saw its shares rise to a new six-year high after the biopharmaceutical company and Genzyme Corp. (Cambridge MA) announced a co-development deal potentially worth more than $1.9 billion involving late-stage cholesterol treatment mipomersen. Genzyme ...
Eli Lilly & Co.(FDA ROUNDUP)(Brief article)
Jan 14, 2008 ... FDA ROUNDUP: Eli Lilly & Co. (Indianapolis IN) won approval to offer its erectile dysfunction drug, Cialis, in a new daily dose. The daily version will take pressure off users who otherwise have a "shot clock" on them or some limited amount of time," Lilly officials said. The daily dose is ...
Weekly stock performance (as of January 11, 2008).(Statistical table)
Jan 14, 2008 ... <Pre> Weekly Stock Performance (as of January 11, 2008) GROUP CLOSE CHGWEEK P/E% CHG RATIO Advanced Med Devices CVS/Caremark 36.77 -0.50 -1.3419.9 ...
U.S. stocks tanked Friday as lower-than-estimated profit forecasts at American Express Co. and Tiffany & Co. heightened concern that the economy is shrinking and sent the Standard & Poor's 500 Index to its worst start since 1982.(Markets)(Brief article)
Jan 14, 2008 ... Markets: U.S. stocks tanked Friday as lower-than-estimated profit forecasts at American Express Co. and Tiffany & Co. heightened concern that the economy is shrinking and sent the Standard & Poor's 500 Index to its worst start since 1982. Adding to the bearish sentiment is the arrival of ...
Included among recent SEC filings for initial public offerings, Alma Lasers Ltd. (Buffalo Grove IL) registered up to $86.30 million worth of common stock via Citigroup Global Markets.(IPO Sector)(Securities and Exchange Commission)(Brief article)
Jan 14, 2008 ... IPO Sector: Included among recent SEC filings for initial public offerings, Alma Lasers Ltd. (Buffalo Grove IL) registered up to $86.30 million worth of common stock via Citigroup Global Markets. No details were furnished about the number of shares to be offered or a price range for each ...
Weekly key rates in percent.(Statistical table)(Brief article)
Jan 14, 2008 ... <Pre> Weekly Key Rates Prev.Year in percent 1/11/08 Week Ago Prime rate 7.25 7.25 8.25 Federal funds4.25 4.25 5.25 3-Month Libor4.26 4.97 5.36 5-Yr. AAA Bank ...
Vitamin D deficiency may increase the risk of heart attacks and stroke in middle age, the results of a new study suggest.(RESEARCH & TECHNOLOGY)(Brief article)
Jan 14, 2008 ... The risk seems to be greatest among people with high blood pressure. Various studies have linked lower vitamin D levels with heart disease and stroke, Dr. Thomas J. Wang and colleagues note in Circulation: Journal of the American Heart Association (1/29). Until now, however, there have ...
HIV, the virus that causes AIDS, depends on more than 250 human genes to grow, a finding that reveals the lethal virus's weakness and may lead to new ways to attack it.(RESEARCH & TECHNOLOGY)(Brief article)
Jan 14, 2008 ... By blocking genes in infected cells, scientists tied the virus's survival to processes of protein transport, entry to the nucleus, and cellular self-destruction, Harvard University scientists said in a study published in the journal Science (1/10). With just nine genes that make 15 ...
John Lechleiter will become Eli Lilly & Co's (Indianapolis IN) chief executive officer, replacing Sidney Taurel, as the company faces a loss of nearly $7 billion in sales to generic competition within six years.(Brief article)
Jan 14, 2008 ... Lechleiter, 54, chief operating officer since October 2005, will become president and CEO on April 1, 2008, Lilly said. He replaces the retiring Taurel, 58, who led the company since July 1998, and remains chairman until the end of this year. Taurel's tenure began as Lilly, the world's ...
Two former sales representatives for Amgen Inc (Thousand Oaks CA) are suing the biotech company, alleging it pushed its sales force to access doctors' confidential medical records to search for potential patients for its psoriasis drug.(Brief article)
Jan 14, 2008 ... The two former representatives, who are seeking lost pay and other compensation, allege they refused to go along with the scheme, which legal experts say violates federal patient privacy law. In addition, the sales reps were encouraged to get insurance companies to give advance approval ...
Roche Holding AG, the world's largest maker of cancer vaccines, said it will teach four more companies in Africa and Asia how to make one of its AIDS vaccines.(Brief article)
Jan 14, 2008 ... Regal Pharmaceuticals in Kenya, CAPS Holdings Ltd. in Zimbabwe, Shelys Pharmaceuticals in Tanzania, and Beximco Pharmaceuticals Ltd. in Bangladesh will gain free access to manufacturing knowledge used to make Roche's saquinavir HIV treatment, ...
Schering-Plough chief stands by Vytorin.(TOP STORIES)(Brief article)
Jan 21, 2008 ... Schering-Plough Chief Stands by Vytorin. Schering-Plough Corp. (Kenilworth NJ) Chief Executive Fred Hassan says the company stands by the effectiveness of its cholesterol drug Vytorin after a study showed it may work no better than an older, less expensive medicine. Doctors and investors ...
Glaxo, AstraZeneca, others probed by EU.(TOP STORIES)(Brief article)
Jan 21, 2008 ... Glaxo, AstraZeneca, Others Probed by EU. GlaxoSmithKline Plc, AstraZeneca Plc and at least seven competitors were raided as part of a European Union probe into whether patents and lawsuit settlements were improperly used to keep generic drugs off the market. Inspectors from the EU's ...
Targeting stem cells can block growth of melanoma.(Report)(Brief article)
Jan 21, 2008 ... Report: Targeting Stem Cells Can Block Growth of Melanoma. Scientists halted the growth of deadly skin cancer by blocking the action of virulent stem cells in a study of mice. The findings, reported in the journal Nature (1/16), lend support to an idea that is gaining increasing acceptance ...
BioSpecifics Technologies Corp. (Nasdaq) led advancing issues, soaring $4.43, or 44% on the week, to $14.40.(Medical Stock Spotlight)(Poinard Pharmaceuticals Inc.)(WellCare Health Plans Inc.)(Brief article)
Jan 21, 2008 ... Medical Stock Spotlight: BioSpecifics Technologies Corp. (Nasdaq) led advancing issues, soaring $4.43, or 44% on the week, to $14.40. The biopharmaceutical company, which has developed and licensed injectable collagenase for three clinical indications, raised $2.1 million in a private ...
Genentech 4Q net rises on Avastin.(TOP STORIES)(Financial report)(Brief article)
Jan 21, 2008 ... Genentech 4Q Net Rises on Avastin. Genentech Inc. (S. San Francisco CA), the world's second-biggest biotech company, said profit climbed 6.4% in the fourth quarter. Sales of its top product, the cancer drug Avastin, fell short of analysts' expectations, however, and shares declined 4% over ...
The U.S. Supreme Court last week turned away an appeal that sought to give terminally ill people greater access to experimental drugs that may save their lives.(Tracking Washington)(Brief article)
Jan 21, 2008 ... Tracking Washington: The U.S. Supreme Court last week turned away an appeal that sought to give terminally ill people greater access to experimental drugs that may save their lives. The justices, without comment, rebuffed a patient-advocacy group that said the Food and Drug Administration ...
Novartis 4Q net profit falls 45%.(CORPORATE)(Financial report)(Brief article)
Jan 21, 2008 ... Novartis 4Q Net Profit Falls 45%. Swiss drugmaker Novartis AG said its profit dropped 45% in the fourth quarter and cited restructuring costs and a weak performance in the U.S. market. Total earnings attributable to shareholders dropped to $904 million (616.4 million euros) in the three ...
NJ subpoenas Amgen records on Enbrel.(CORPORATE)(Brief article)
Jan 21, 2008 ... NJ Subpoenas Amgen Records on Enbrel. New Jersey investigators on Thursday said they have subpoenaed records from Amgen Inc. (Thousand Oaks CA) following accusations that the biotech company pushed its sales force to violate patient confidentiality laws and market a drug for unapproved ...
Humana Inc.(CORPORATE)(Brief article)
Jan 21, 2008 ... HUMANA INC. (Louisville KY), the second largest provider of health plans to the elderly, was fined $500,000 by Illinois regulators for using unlicensed agents to sell products sponsored by the U.S. Medicare program. The company agreed to pay the fine and file a compliance plan with the ...
Novo Nordisk A/S.(CORPORATE)(Brief article)
Jan 21, 2008 ... NOVO NORDISK A/S. discontinued its experimental AERx inhaler and took a charge of 1.3 billion Danish kroner ($260 million) in 2007, saying the product offered no clinical benefit. The decision by Novo, the world's biggest insulin producer, ...
Odyssey Healthcare Inc.(CORPORATE)(Brief article)
Jan 21, 2008 ... ODYSSEY HEALTHCARE INC. (Dallas TX) said it agreed to acquire fellow hospice care provider VistaCare Inc. (Scottsdale AZ) for $8.60 per share, or about $147.1 million. Odyssey said the deal includes a cash tender offer for all outstanding shares of VistaCare common stock, following a cash ...
Helicos Biosciences Corp.(CORPORATE)(Brief article)
Jan 21, 2008 ... HELICOS BIOSCIENCES CORP. (Cambridge MA) said it received a $20 million senior secured credit facility it will use for working capital and product marketing efforts. Helicos received $10 million from the facility on Dec ....
Elan Corp., Ireland's biggest drugmaker, and partner Biogen Idec Inc. (Cambridge MA) won approval for the use of their multiple sclerosis medicine Tysabri as a treatment for Crohn's disease.(FDA ROUNDUP)(Brief article)
Jan 21, 2008 ... FDA ROUNDUP: Elan Corp., Ireland's biggest drugmaker, and partner Biogen Idec Inc. (Cambridge MA) won approval for the use of their multiple sclerosis medicine Tysabri as a treatment for Crohn's disease. The condition involves a chronic inflammation of the intestines that affects about 1 ...
Weekly stock performance (as of January 18, 2008).(Statistical table)
Jan 21, 2008 ... <Pre> Weekly Stock Performance (as of January 18, 2008) GROUP CLOSE CHG WEEKP/E % CHG RATIO Providers/HMOs CVS/Caremark 36.92 +0.15+0.41 20.0 ...
U.S. stocks fell Friday, sending the Standard & Poor's 500 Index to its biggest weekly loss in five years, on concern President George W. Bush's $150 billion plan to revive the economy will fail to prevent a recession.(Markets)(Brief article)
Jan 21, 2008 ... Markets: U.S. stocks fell Friday, sending the Standard & Poor's 500 Index to its biggest weekly loss in five years, on concern President George W. Bush's $150 billion plan to revive the economy will fail to prevent a recession. The day's trading Friday reflected how peevish Wall Street has ...
Included among recent SEC filings for initial public offerings, Omeros Corporation (Seattle WA) registered up to $115 million worth of common stock via Deutsche Bank Securities.(IPO Sector)(Brief article)
Jan 21, 2008 ... IPO Sector: Included among recent SEC filings for initial public offerings, Omeros Corporation (Seattle WA) registered up to $115 million worth of common stock via Deutsche Bank Securities. No details were furnished about the number of shares to be offered or a price range for each share ....
Weekly key rate in percent.(Statistical table)(Brief article)
Jan 21, 2008 ... <Pre> Weekly Key Rate Prev. Year in percent1/18/08 Week Ago Prime rate 7.25 7.25 8.25 Federal funds4.25 4.25 5.25 3-Month Libor4.26 4.26 5.36 5-Yr. AAA Bank 4.38 4.38 ...
Gene changes in five chromosome regions appear to have a combined effect for increasing the risk of prostate cancer, according to a report in The New England Journal of Medicine (1/16).(RESEARCH & TECHNOLOGY)(Brief article)(Clinical report)
Jan 21, 2008 ... Gene changes in five chromosome regions appear to have a combined effect for increasing the risk of prostate cancer, according to a report in The New England Journal of Medicine (1/16). Previous reports have linked several of these changes or "variants" with prostate cancer, but with each ...
People who eat lots of yellow or dark leafy vegetables, as well as foods rich in vitamin E, may be reducing their risk of developing cataracts, according to new research published in the Archives of Ophthalmology (1/8).(RESEARCH & TECHNOLOGY)(Brief article)(Clinical report)
Jan 21, 2008 ... People who eat lots of yellow or dark leafy vegetables, as well as foods rich in vitamin E, may be reducing their risk of developing cataracts, according to new research published in the Archives of Ophthalmology (1/8). "Although definitive data to guide public health recommendations ...
Studies of antidepressants that concluded the medicines were effective were more likely to be published in medical journals than studies showing failed results, according to researchers.(Brief article)
Jan 21, 2008 ... Studies of antidepressants that concluded the medicines were effective were more likely to be published in medical journals than studies showing failed results, according to researchers. The study compared published research on 12 medicines, including Wyeth's (Madison NJ) Effexor and ...
Federal regulators have ordered medical device maker Stryker Corp (Kalamazoo MI) to fix a host of long-standing problems in its manufacturing of hip replacement parts that have triggered multiple patient complaints and forced some to have follow-up surgeries.(Brief article)
Jan 21, 2008 ... Federal regulators have ordered medical device maker Stryker Corp (Kalamazoo MI) to fix a host of long-standing problems in its manufacturing of hip replacement parts that have triggered multiple patient complaints and forced some to have follow-up surgeries. The U.S. Food and Drug ...
Pfizer Inc (New York) strengthened the warning for its anti-smoking pill Chantix and told doctors to watch patients for abnormal behavior after the violent death of a rock musician using the drug led to added reports of side effects.(Brief article)
Jan 21, 2008 ... Pfizer Inc (New York) strengthened the warning for its anti-smoking pill Chantix and told doctors to watch patients for abnormal behavior after the violent death of a rock musician using the drug led to added reports of side effects. A possible link between the drug and reports of ...